Skip to main content
Visual Computing for Industry, Biomedicine, and Art

Table 3 The classification results of ResNet18, VGG16 and ResNet50 at patient level

From: Discrimination between leucine-rich glioma-inactivated 1 antibody encephalitis and gamma-aminobutyric acid B receptor antibody encephalitis based on ResNet18

 

Delong Test

AUC

Accuracy

Sensitivity

Specificity

ResNet18

Reference

0.98

96.30% (78/81)

94.12% (16/17)

96.88% (62/64)

VGG16

0.0003

0.73

55.56% (45/81)

88.24% (15/17)

46.88% (30/64)

ResNet50

0.0097

0.86

86.42% (70/81)

52.94% (9/17)

95.31% (61/64)

  1. For the patient level, the sensitivity and specificity refer to the ratio of successfully identifying the patients with GABAB receptor antibody encephalitis and that successfully identifying the patients with LGI1 antibody encephalitis, respectively
Back to article page